FEATURED ARTICLES
Hidden Compliance Risks In Start-Up That Could Derail Your Clinical Trial
Kulkarni Law Firm Senior Attorney Edye T. Edens explores the risks embedded in clinical trial start-up activities, such as site activation, contract execution, delegation of responsibilities, and cross-border data flows.
-
![AI artificial intelligence chatbot-GettyImages-1598676527]( "What's The Risk Of Letting Researchers Use LLMs?")
What's The Risk Of Letting Researchers Use LLMs?Who should be using AI and how? Sage Therapeutics' Jake Alme explores AI use in clinical research, examining its use shifting toward more complex applications and discussing the risk of using it in the public domain.
-
![CTD Optimization]( "Celebrating Clinical Trials Day, Part 2: Trial Optimization In Action")
Celebrating Clinical Trials Day, Part 2: Trial Optimization In ActionCelebrate Clinical Trials Day 2025 with these industry experts as they share experiences and advice related to trial design, regulatory and compliance, and outsourcing challenges.
-
![digital effect, dynamic transitions, high-tech visual-GettyImages-2198367989]( "5 Ways AI Is Changing Clinical Research — And How To Embrace It")
5 Ways AI Is Changing Clinical Research — And How To Embrace ItDiscover how AI is transforming clinical trials, learn real tools already in use, and get practical guidance for clinical professionals — especially CRAs and site teams — looking to upskill in an AI-enhanced environment.
SERVICES & PRODUCTS
“Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”
Raffaella Hart, MS, CIP
Sr. Vice President, IRB and IBC Services
Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.
Experience customized and validated flow cytometry (FCM) biomarkers and panels for your clinical research on a global scale. Learn how FCM can enhance your research and help develop the panels you need.
Gain expert guidance and connect with a global network of qualified QPPVs and LPPVs, who will ensure compliance with pharmacovigilance regulations and tailor their approach to your product launch strategy.